Ann: US FDA clearance of Hailie for AstraZeneca inhalers, page-64

IMO there is no shorting in this event.

CR was done back in 2020 180M Shares @3c. VWAP during 2023 is around 5.5c however with low volume.
According to T20 remaining the same at end of 2023. So it is quite low volume to exist for profit.

Yesterday would of fit right in for taking profit if you in T20 after 4 year investment. question is why would you want to exist now when it about to commercialized stage. I would say they have been free carried. thus only 77M traded.
77M was swapped handed new blood or day trader.
Those day trade already exist last 2 days. those remaining would of take position in average down now.

So not because of consolidation .... iMO there still room for sp to move down so consolidate is out of question.

Now SP has entered low cap, oversold, closed to ATL. with above scenario i think we will see some improve in sp.
CR or not the quarterly will indicates this imo.